TABLE-Stella Pharma - 6-MTH parent results

About this update from Stella Pharma Corporation

Nov 13 (Reuters)- Stella Pharma Corporation PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2025 Sep 30, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 200 mln 169 mln 377 mln (+18.2 pct) (+10.0 pct) (-60.7 pct) Operating loss 298 mln loss 269 mln loss 922 mln Recurring loss 306 mln loss 267 mln loss 908 mln Net loss 307 mln loss 268 mln loss 911 mln EPS loss 9.05 yen loss 8.21 yen loss 26.80 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Stella Pharma Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T

View stock analysis, news, and events for Stella Pharma Corporation